Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program

被引：16
|
作者：
Turner, Philip J. [1 ]
机构：
[1] AstraZeneca, Infect Discovery Dept, Macclesfield SK10 4TG, Cheshire, England
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2006年 / 56卷 / 03期
关键词：
Pseudomonas aeruginosa; susceptibility; meropenem; imipenem;
D O I：
10.1016/j.diagmicrobio.2006.07.015
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
This article examines the activity of meropenem and imipenem against Pseudomonas aeruginosa isolates from the Meropenem Yearly Susceptibility Test Information Collection program between 1997 and 2005. In particular, it examines the activity of meropenem against imipenem-resistant strains and vice versa. Meropenem proved to be active against up to a 3rd of imipenem-resistant strains. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码：341 / 344
页数：4
相关论文
共 50 条
  • [21] IN-VITRO ACTIVITY OF BIAPENEM, COMPARED WITH IMIPENEM AND MEROPENEM, AGAINST PSEUDOMONAS-AERUGINOSA STRAINS AND MUTANTS WITH KNOWN RESISTANCE MECHANISMS
    CHEN, HY
    LIVERMORE, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (05) : 949 - 958
  • [22] Resistance to imipenem and zinc in clinical isolates of Pseudomonas aeruginosa
    Velasco, Carmen
    Rodriguez, Jos Manuel
    Conejo, M. Carmen
    Pascual, Alvaro
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (04) : 377 - 378
  • [23] Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa
    Wang, Leilei
    Zhang, Xuefei
    Zhou, Xun
    Yang, Fan
    Guo, Qinglan
    Wang, Minggui
    MICROBIOLOGY SPECTRUM, 2023, 11 (03):
  • [24] IMIPENEM ANTAGONISM OF THE INVITRO ACTIVITY OF PIPERACILLIN AGAINST PSEUDOMONAS-AERUGINOSA
    BERTRAM, MA
    YOUNG, LS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) : 272 - 274
  • [25] Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa
    Hagihara, Mao
    Kuti, Joseph L.
    Nicolau, David P.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 72 (03) : 258 - 262
  • [26] Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases
    Mushtaq, Shazad
    Meunier, Daniele
    Vickers, Anna
    Woodford, Neil
    Livermore, David M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (02) : 434 - 442
  • [27] In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains
    Drulis-Kawa, Zuzanna
    Gubernator, Jerzy
    Dorotkiewicz-Jach, Agata
    Doroszkiewicz, Wlodzimierz
    Kozubek, Arkadiusz
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 315 (1-2) : 59 - 66
  • [28] Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa
    Sophonsri, Anthony
    Kalu, Michelle
    Wong-Beringer, Annie
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [29] In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)
    Hernandez-Garcia, Marta
    Garcia-Castillo, Maria
    Melo-Cristino, Jose
    Pinto, Margarida F.
    Goncalves, Elsa
    Alves, Valquiria
    Raquel Vieira, Ana
    Ramalheira, Elmano
    Sancho, Luisa
    Diogo, Jose
    Ferreira, Rui
    Cruz, Hugo
    Chaves, Catarina
    Bou, German
    Cercenado, Emilia
    Delgado-Valverde, Mercedes
    Oliver, Antonio
    Pitart, Cristina
    Rodriguez-Lozano, Jesus
    Tormo, Nuria
    Diaz-Reganon, Jazmin
    Passaro, Leonor
    Duarte, Joana
    Canton, Rafael
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (11) : 3163 - 3172
  • [30] In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Ruiz, Victor H.
    Fratoni, Andrew
    Nicolau, David P.
    Kuti, Joseph L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023,
12345